Select Publications

Journal articles

Joseph M; Alvarado R; Jonker BP; Winder MJ; Earls P; Campbell R; Kalish LH; Sacks R; Davidson AS; McCormack A; Harvey RJ, 2024, 'Headache in Patients with Sellar Disease: Clinicomorphological Predictors of Headache and the Outcome of Endoscopic Transsphenoidal Surgery', Journal of Neurological Surgery, Part B: Skull Base, 85, pp. 247 - 254, http://dx.doi.org/10.1055/a-2036-0652

De Sousa SMC; McCormack A; Orsmond A; Shen A; Yates CJ; Clifton-Bligh R; Santoreneos S; King J; Feng J; Toubia J; Torpy DJ; Scott HS, 2024, 'Increased prevalence of germline pathogenic CHEK2 variants in individuals with pituitary adenomas.', J Clin Endocrinol Metab, http://dx.doi.org/10.1210/clinem/dgae268

Petersenn S; Fleseriu M; Casanueva FF; Giustina A; Biermasz N; Biller BMK; Bronstein M; Chanson P; Fukuoka H; Gadelha M; Greenman Y; Gurnell M; Ho KKY; Honegger J; Ioachimescu AG; Kaiser UB; Karavitaki N; Katznelson L; Lodish M; Maiter D; Marcus HJ; McCormack A; Molitch M; Muir CA; Neggers S; Pereira AM; Pivonello R; Post K; Raverot G; Salvatori R; Samson SL; Shimon I; Spencer-Segal J; Vila G; Wass J; Melmed S, 2024, 'Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)', Nature Reviews Endocrinology, 20, pp. 62, http://dx.doi.org/10.1038/s41574-023-00916-2

Lenders NF; Thompson TJ; Chui J; Low J; Inder WJ; Earls PE; McCormack AI, 2024, 'Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2', Pituitary, http://dx.doi.org/10.1007/s11102-024-01385-0

Petersenn S; Fleseriu M; Casanueva FF; Giustina A; Biermasz N; Biller BMK; Bronstein M; Chanson P; Fukuoka H; Gadelha M; Greenman Y; Gurnell M; Ho KKY; Honegger J; Ioachimescu AG; Kaiser UB; Karavitaki N; Katznelson L; Lodish M; Maiter D; Marcus HJ; McCormack A; Molitch M; Muir CA; Neggers S; Pereira AM; Pivonello R; Post K; Raverot G; Salvatori R; Samson SL; Shimon I; Spencer-Segal J; Vila G; Wass J; Melmed S, 2023, 'Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement', Nature Reviews Endocrinology, 19, pp. 722 - 740, http://dx.doi.org/10.1038/s41574-023-00886-5

Arima H; Cheetham T; Christ-Crain M; Cooper DL; Drummond JB; Gurnell M; Levy M; McCormack A; Newell-Price JD; Verbalis JG; Wass J, 2023, 'Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus', Hormone Research in Paediatrics, 96, pp. 423 - 425, http://dx.doi.org/10.1159/000527139

Lenders NF; Earls PE; Wilkinson AC; Costin M; Hofer M; Shein TT; Harvey RJ; Krishnan G; Picallo M; Pal A; Wass J; McCormack AI, 2023, 'Predictors of pituitary tumour behaviour: An analysis from long-Term follow-up in 2 tertiary centres', European Journal of Endocrinology, 189, pp. 106 - 114, http://dx.doi.org/10.1093/ejendo/lvad079

Trouillas J; Burman P; Losa M; McCormack A; Petersenn S; Popovic V; Theodoropoulou M; Dekkers OM; Raverot G, 2023, 'Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the question', European journal of endocrinology, 188, http://dx.doi.org/10.1093/ejendo/lvad042

Arima H; Cheetham T; Christ-Crain M; Cooper D; Drummond J; Gurnell M; Levy M; Mccormack A; Newell-Price J; Verbalis JG; Wass J; Arima H, 2023, 'Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus', Journal of Clinical Endocrinology and Metabolism, 108, pp. 1 - 3, http://dx.doi.org/10.1210/clinem/dgac547

De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A, 2023, 'Pituitary tumours: molecular and genetic aspects', Journal of Endocrinology, 257, http://dx.doi.org/10.1530/JOE-22-0291

Lenders NF; Earls PE; Inder WJ; McCormack AI, 2023, 'The evolution in pituitary tumour classification: a clinical perspective.', Endocr Oncol, 3, pp. e220079, http://dx.doi.org/10.1530/EO-22-0079

Arima H; Cheetham T; Christ-Crain M; Cooper D; Drummond J; Gurnell M; Levy M; McCormack A; Newell-Price J; Verbalis JG; Wass J; Working Group for Renaming Diabetes Insipidus , 2022, 'Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.', J Clin Endocrinol Metab, 108, pp. 1 - 3, http://dx.doi.org/10.1210/clinem/dgac547

Arima H; Bichet DG; Cheetham T; Christ-Crain M; Drummond J; Gurnell M; Levy M; McCormack A; Newell-Price J; Verbalis JG; Wass J; Cooper D, 2022, 'Changing the name of diabetes insipidus', Pituitary, 25, pp. 777 - 779, http://dx.doi.org/10.1007/s11102-022-01276-2

Lenders NF; Chui J; Low J; Inder WJ; Earls PE; McCormack AI, 2022, 'Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours', Pituitary, 25, pp. 997 - 1003, http://dx.doi.org/10.1007/s11102-022-01284-2

McCormack A, 2022, 'Temozolomide in aggressive pituitary tumours and pituitary carcinomas', Best Practice and Research: Clinical Endocrinology and Metabolism, 36, http://dx.doi.org/10.1016/j.beem.2022.101713

Arima H; Cheetham T; Christ-Crain M; Cooper D; Gurnell M; Drummond JB; Levy M; McCormack AI; Verbalis J; Newell-Price J; Wass JAH, 2022, 'Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus', Endocrine Connections, 11, http://dx.doi.org/10.1530/EC-22-0378

Working Group for Renaming Diabetes Insipidus ; Arima H; Cheetham T; Christ-Crain M; Cooper D; Gurnell M; Drummond JB; Levy M; McCormack AI; Verbalis J; Newell-Price J; Wass JAH, 2022, 'Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.', Eur J Endocrinol, 187, pp. P1 - P3, http://dx.doi.org/10.1530/EJE-22-0751

Burman P; Trouillas J; Losa M; McCormack A; Petersenn S; Popovic V; Theodoropoulou M; Raverot G; Dekkers OM; Guenego A; Micko A; Hubalewska-Dydejezky A; Troendle A; Rasmussen ÅK; Whitelaw B; Decoudier B; Ekman B; Engström BE; Höybye C; Jublanc C; Rudelli CC; Higham C; Garcia C; Bresson D; Henley D; Larrieu-Ciron D; Maiter D; Laws ER; Christ E; Kuhn E; Ceccato F; Schillo F; Castinetti F; Mantovani G; Vila G; Lasolle H; Garay IB; Kralievic I; Jorgensen JOL; Berinder K; Ritzel K; Bach L; Ortiz LD; Criniere L; Syro L; Haissaguerre M; Zatelli MC; Batisse-Lignier M; Jaffrain-Rea ML; Korbonits M; Ragonese M; Reincke M; Toth M; Bourcigaux N; Chevalier N; Ragnarsson O; Chanson P; Pekic S; Mallea-Gil S; Usui T; Deutschbein TLMT; Dusek T; Feldt-Rasmussen U; Greenman Y, 2022, 'Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients', European Journal of Endocrinology, 187, pp. 593 - 605, http://dx.doi.org/10.1530/EJE-22-0440

Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K, 2022, 'MEN4, the MEN1 Mimicker: A Case Series of Three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations', Journal of Clinical Endocrinology and Metabolism, 107, pp. 2339 - 2349, http://dx.doi.org/10.1210/clinem/dgac162

Boguszewski MCS; Boguszewski CL; Chemaililly W; Cohen LE; Gebauer J; Higham C; Hoffman AR; Polak M; Yuen KCJ; Alos N; Antal Z; Bidlingmaier M; Biller BMK; Brabant G; Choong CSY; Cianfarani S; Clayton PE; Coutant R; Cardoso-Demartini AA; Fernandez A; Grimberg A; Guðmundsson K; Guevara-Aguirre J; K Y Ho K; Horikawa R; Isidori AM; Otto Lunde Jørgensen J; Kamenicky P; Karavitaki N; Kopchick JJ; Lodish M; Luo X; McCormack AI; Meacham L; Melmed S; Moab SM; Müller HL; Neggers SJCMM; Aguiar Oliveira MH; Ozono K; Pennisi PA; Popovic V; Radovick S; Savendahl L; Touraine P; van Santen HM; Johannsson G, 2022, 'Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement', European Journal of Endocrinology, 186, pp. 35 - 52, http://dx.doi.org/10.1530/EJE-21-1186

Raven LM; Mccormack AI; Greenfield JR, 2022, 'Letter to the Editor From Raven et al: "Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine"', Journal of Clinical Endocrinology and Metabolism, 107, pp. E1767 - E1768, http://dx.doi.org/10.1210/clinem/dgab822

Raven LM; McCormack AI, 2022, 'Female Representation: Australian Diabetes and Endocrinology Societies', Frontiers in Endocrinology, 13, http://dx.doi.org/10.3389/fendo.2022.842909

Wang R; Zhou C; McCormack AI; Mamelak AN, 2022, 'Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments', Frontiers in Endocrinology, 13, http://dx.doi.org/10.3389/fendo.2022.868174

Tritos NA; Fazeli PK; McCormack A; Mallea-Gil SM; Pineyro MM; Christ-Crain M; Frara S; Labadzhyan A; Ioachimescu AG; Shimon I; Takahashi Y; Gurnell M; Fleseriu M; Bancos I; Bidlingmaier M; Biermasz N; Boguszewski CL; Brzana J; Carmichael J; Chanson P; Drincic A; Eisenberg Y; Fukuoka H; Gadelha M; Ghalib L; Gordon M; Greenman Y; Guarda F; Hinojosa-Amaya M; Ho K; Ilie MD; Karavitaki N; Katznelson L; Keleştimur F; Lacroix A; Langlois F; Lim D; Neggers S; Niculescu D; Petersenn S; Pivonello R; Raverot G; Ross R; Salvatori R; Scaroni C; Shafiq I; Sharma S; Tabarin A; Tsagarakis S; Valassi E; Vila G; Wierman M, 2022, 'Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas', Pituitary, 25, pp. 64 - 73, http://dx.doi.org/10.1007/s11102-021-01170-3

Arima H; Cheetham T; Christ-Crain M; Cooper DL; Drummond JB; Gurnell M; Levy M; McCormack A; Newell-Price JD; Verbalis JG; Wass J, 2022, 'Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus', Archives of Endocrinology and Metabolism, 66, pp. 868 - 870, http://dx.doi.org/10.20945/2359-3997000000528

Arima H; Cheetham T; Christ-Crain M; Cooper D; Drummond J; Gurnell M; Levy M; McCormack A; Newell-Price J; Verbalis JG; Wass J, 2022, 'Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus', Clinical Endocrinology, http://dx.doi.org/10.1111/cen.14819

Stroud A; Dhaliwal P; Harvey RJ; Alvarado R; Jonker BP; Winder MJ; Grayson JW; McCormack A, 2022, 'Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing's disease.', Endocr Oncol, 2, pp. 19 - 31, http://dx.doi.org/10.1530/EO-21-0026

Fleseriu M; Auchus R; Bancos I; Ben-Shlomo A; Bertherat J; Biermasz NR; Boguszewski CL; Bronstein MD; Buchfelder M; Carmichael JD; Casanueva FF; Castinetti F; Chanson P; Findling J; Gadelha M; Geer EB; Giustina A; Grossman A; Gurnell M; Ho K; Ioachimescu AG; Kaiser UB; Karavitaki N; Katznelson L; Kelly DF; Lacroix A; McCormack A; Melmed S; Molitch M; Mortini P; Newell-Price J; Nieman L; Pereira AM; Petersenn S; Pivonello R; Raff H; Reincke M; Salvatori R; Scaroni C; Shimon I; Stratakis CA; Swearingen B; Tabarin A; Takahashi Y; Theodoropoulou M; Tsagarakis S; Valassi E; Varlamov EV; Vila G; Wass J; Webb SM; Zatelli MC; Biller BMK, 2021, 'Consensus on diagnosis and management of Cushing's disease: a guideline update', The Lancet Diabetes and Endocrinology, 9, pp. 847 - 875, http://dx.doi.org/10.1016/S2213-8587(21)00235-7

McCormack A, 2021, 'Childhood-onset prolactinomas—Should earlier surgery be considered?', Clinical Endocrinology, 95, pp. 571 - 573, http://dx.doi.org/10.1111/cen.14477

Lenders NF; Inder WJ; McCormack AI, 2021, 'Towards precision medicine for clinically non-functioning pituitary tumours', Clinical Endocrinology, 95, pp. 398 - 409, http://dx.doi.org/10.1111/cen.14472

Chang N; Grayson JW; Mangussi-Gomes J; Fung S; Alvarado R; Winder M; Jonker BP; McCormack A; Harvey RJ, 2021, 'Assessment of magnetic resonance imaging criteria for the diagnosis of cavernous sinus invasion by pituitary tumors', Journal of Clinical Neuroscience, 90, pp. 262 - 267, http://dx.doi.org/10.1016/j.jocn.2021.06.010

Grayson JW; Nayak A; Winder M; Jonker B; Alvarado R; Barham H; Mccormack A; Harvey RJ, 2021, 'Multidisciplinary Team Care in the Surgical Management of Pituitary Adenoma', Journal of Neurological Surgery, Part B: Skull Base, 82, pp. 295 - 302, http://dx.doi.org/10.1055/s-0039-1700498

Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI, 2021, 'Transcription Factor Immunohistochemistry in the Diagnosis of Pituitary Tumors', Journal of the Endocrine Society, 5, pp. A651 - A651, http://dx.doi.org/10.1210/jendso/bvab048.1327

Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI, 2021, 'Transcription factor immunohistochemistry in the diagnosis of pituitary tumours', European Journal of Endocrinology, 184, pp. 891 - 901, http://dx.doi.org/10.1530/EJE-20-1273

Lamb LS; Sim HW; McCormack AI, 2020, 'Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy', Frontiers in Endocrinology, 11, pp. 576027, http://dx.doi.org/10.3389/fendo.2020.576027

Stroud A; Dhaliwal P; Alvarado R; Winder MJ; Jonker BP; Grayson JW; Hamizan A; Harvey RJ; McCormack A, 2020, 'Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis', Pituitary, 23, pp. 595 - 609, http://dx.doi.org/10.1007/s11102-020-01066-8

Fleseriu M; Buchfelder M; Cetas JS; Fazeli PK; Mallea-Gil SM; Gurnell M; McCormack A; Pineyro MM; Syro LV; Tritos NA; Marcus HJ, 2020, 'Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective', Pituitary, 23, pp. 327 - 337, http://dx.doi.org/10.1007/s11102-020-01059-7

Wang M; Jonker B; Killen L; Bogum Y; McCormack A; Bishay RH, 2020, 'Fatal high-grade skull osteosarcoma 30 years following radiotherapy for Cushing’s disease', Endocrinology, Diabetes and Metabolism Case Reports, 2020, pp. 1 - 7, http://dx.doi.org/10.1530/EDM-20-0062

Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Dekkers O; Popovic V; Wierinckx A; McCormack A; Petersenn S; Burman P; Raverot G; Villa C, 2020, 'Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions', Reviews in Endocrine and Metabolic Disorders, 21, pp. 243 - 251, http://dx.doi.org/10.1007/s11154-020-09562-9

Burman P; Lamb L; McCormack A, 2020, 'Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives', Reviews in Endocrine and Metabolic Disorders, 21, pp. 263 - 276, http://dx.doi.org/10.1007/s11154-020-09551-y

Cho J; Grayson JW; Christensen J; Winder MJ; Sheehy J; Steel T; Bentivoglio P; Barham HP; McCormack A; Harvey RJ, 2020, 'Long-Term Sinonasal Function Following Transnasal Pituitary Surgery: A Comparison of Surgical Approach', American Journal of Rhinology and Allergy, 34, pp. 361 - 368, http://dx.doi.org/10.1177/1945892419896788

Lenders NF; McCormack AI; Ho KKY, 2020, 'Management of endocrine disease: Does gender matter in the management of acromegaly?', European Journal of Endocrinology, 182, pp. R67 - R82, http://dx.doi.org/10.1530/EJE-19-1023

Lamb LS; Sim HW; McCormack AI, 2020, 'Exploring the role of novel medical therapies for aggressive pituitary tumors: A review of the literature—“are we there yet?”', Cancers, 12, pp. 308, http://dx.doi.org/10.3390/cancers12020308

De Sousa SMC; Baranoff J; Rushworth RL; Butler J; Sorbello J; Vorster J; Thompson T; Mccormack AI; Inder WJ; Torpy DJ, 2020, 'Impulse Control Disorders in Dopamine Agonist-Treated Hyperprolactinemia: Prevalence and Risk Factors', Journal of Clinical Endocrinology and Metabolism, 105, http://dx.doi.org/10.1210/clinem/dgz076

McCabe M; Gauthier M-E; Chan C-L; Thompson T; De Sousa S; Puttick C; Grady J; Gayevskiy V; Tao J; Ying K; Cipponi A; Deng N; Swarbrick A; Thomas M; kConFab ; Lord R; Johns A; Kohonen-Corish M; O'Toole S; Clark J; Mueller S; Gupta R; McCormack A; Dinger M; Cowley M; Bastick P; Friedlander M; Colley A; Andrews L; Young M-A; Tucker K; Williams R, 2019, 'Development and validation of a targeted gene sequencing panel for application to disparate cancers', Scientific Reports, 9, pp. 17052, http://dx.doi.org/10.1038/s41598-019-52000-3

Stroud A; Zhang J; McCormack A, 2019, 'Diagnosing Cushing’s disease in the context of chronic kidney disease: A case report and literature review', European Journal of Endocrinology, 181, pp. K29 - K35, http://dx.doi.org/10.1530/EJE-19-0326

McCabe MJ; Pinese M; Chan CL; Sheriff N; Thompson TJ; Grady J; Wong M; Gauthier MEA; Puttick C; Gayevskiy V; Hajdu E; Wong SQ; Barrett W; Earls P; Lukeis R; Cheng YY; Lin RCY; Thomas DM; Watkins DN; Dinger ME; McCormack AI; Cowley MJ; Wong-Erasmus M, 2019, 'Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases', Cold Spring Harbor Molecular Case Studies, 5, pp. a003764, http://dx.doi.org/10.1101/mcs.a003764

Trainer PJ; Newell-Price JDC; Ayuk J; Aylwin SJB; Rees A; Drake W; Chanson P; Brue T; Webb SM; Fajardo C; Aller J; McCormack AI; Torpy DJ; Tachas G; Atley L; Ryder D; Bidlingmaier M, 2018, 'A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly', European Journal of Endocrinology, 179, pp. 97 - 108, http://dx.doi.org/10.1530/EJE-18-0138

Trouillas J; Burman P; McCormack A; Petersenn S; Popovic V; Dekkers O; Raverot G, 2018, 'Aggressive pituitary tumours and carcinomas: Two sides of the same coin?', European Journal of Endocrinology, 178, pp. C7 - C9, http://dx.doi.org/10.1530/EJE-18-0250

Lenders N; McCormack A, 2018, 'Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)', Pituitary, 21, pp. 217 - 229, http://dx.doi.org/10.1007/s11102-017-0857-z


Back to profile page